Inhibition of Voriconazole Metabolism by Chloramphenicol in an Adolescent with Central Nervous System Aspergillosis

Verena Häfner, Nadine Albermann, Walter E. Haefeli, Friedrich Ebinger

Antimicrobial Agents and Chemotherapy · 2008 · 15 citations · 18 references

DOIFull text

Open access

Concepts

Abstract

For an adolescent with bacterial meningitis and subsequent cerebral aspergillosis, intravenous voriconazole dose requirements substantially decreased during coadministration with intravenous chloramphenicol and considerably rose after discontinuation of the antibiotic. In agreement with in vitro evidence, these data suggest that chloramphenicol is a rather significant inhibitor of hepatic CYP3A4 and/or CYP2C19.

References

18